A: Antimicrobial Agents Including Antibacterial, Antiviral, and Antifungal Drugs
A1. Novel agents
A2. Pharmacokinetics and Pharmacodynamics studies
A3. Resistance mechanisms
A4. Treatment of antimicrobial resistant infections
A5. Pharmacogenetics
A6. New drug development (formerly L3)
B: Basic Science and Translational Studies of Microbial Pathogenesis and Infectious Diseases
B1. Studies of correlates of protection (or biomarkers) against microbial infection and disease in patients or experimental models
B2. Studies of the immune response to microbial infection and disease in patients or experimental models
B3. Studies of genetic factors that govern susceptibility to microbial infection and disease
B4. Studies of microbial factors that govern susceptibility to microbial infection and disease
B5. Studies at the interface of host-microbe interaction
B6. Microbiome science
C: Clinical Infectious Diseases
C1. Clinical trials
C2. Bone and joint
C3. Skin and soft tissue
C4. Respiratory infections - viral
C5. Respiratory infections - bacterial
C6. Enteric infection
C7. Bacteremia
C8. Endocarditis
C9. CNS infection
C10. Sexually transmitted infections
C11. UTIs
C12. Social determinants of health
D: Infectious Disease Diagnostics
D1. Diagnostics: Bacteriology/mycobacteriology
D2. Diagnostics: Virology
D3. Diagnostics: Parasitology
D4. Diagnostics: Mycology
D5. Diagnostics: Typing/sequencing
D6. Diagnostics: New diagnostics (formerly L2)
D7. Diagnostics: Other (e.g., host response biomarkers, molecular imaging, metabolomics/proteomics, etc.)
E: Infectious Diseases Medical Education (scholarly work directed at enhancing infectious diseases education of trainees and/or health professionals, social determinants of health)
F: Hepatitis (all HIV co-infection abstracts should be submitted to Category H)
F1. Hepatitis A
F2. Hepatitis B
F3. Hepatitis C
F4. Hepatitis E
G: Global Health (e.g., travel medicine, tropical medicine and parasitology, endemic/epidemic diseases of resource-challenged areas, social determinants of health)
H: HIV/AIDS, other retroviruses, and co-infections
H1. Epidemiology and screening
H2. Prevention
H3. Pathogenesis
H4. Treatment
H5. Complications and co-infections
H6. Social determinants of health
I: Adult and Pediatric Vaccines
I1. Adult vaccines
I2. Pediatric vaccines
I3. Adolescent vaccines
I4. New vaccines (formerly L3)
J: Clinical Practice Issues (e.g., billing, medical records & informatics, healthcare reform, home health/OPAT)
K: Tuberculosis and other Mycobacterial Infections
M: Medical Mycology
M1. Clinical studies of fungal infections
M2. Studies of fungal pathogenesis in patients with immune impairment
M3. Studies of the pathogenesis of fungal infections
N: Healthcare Epidemiology and Prevention
N1. Health Care-Associated Infections: Occupational infection prevention
N2. Health Care-Associated Infections: Surveillance
N3. Health Care-Associated Infections: Epidemiologic methods
N4. Health Care-Associated Infections: Device-associated (CLABSI, CAUTI, VAP)
N5. Health Care-Associated Infections: Disinfection/sterilization & environmental infection prevention
N6. Health Care-Associated Infections: Hand hygiene/transmission-based precautions
N7. Health Care-Associated Infections: Surgical site infections
N8. Health Care-Associated Infections: C. difficile
N9. Health Care-Associated Infections: Gram-positives (MRSA, MSSA, VRE)
N10. Health Care-Associated Infections: Gram-negatives (MDR-GNR)
N11. Health Care-Associated Infections: Outbreaks
N12. Health Care-Associated Infections: Non-acute care
N13. Health Care-Associated Infections: Non-bacterial (fungal, viral)
N14. Health Care-Associated Infections: Social determinants of health
O: Public Health (Studies on issues pertaining to preparedness for and response to outbreaks of infectious diseases including those linked to agents of bioterror, foodborne, waterborne, vector borne, and zoonotic diseases, vaccine-preventable diseases and social determinants of health)
P: Pediatric and Perinatal Infections
P1. Pediatric: Bacterial studies (natural history and therapeutic)
P2. Pediatric: Fungal studies (natural history and therapeutic)
P3. Pediatric: Viral studies (natural history and therapeutic)
P4. Pediatric: Antimicrobial stewardship (inpatient/outpatient pediatric focused)
P5. Pediatric: Healthcare-associated infection epidemiology and prevention
P6. Pediatric: HIV
P7. Pediatric: Maternal-child infections
P8. Pediatric: Social determinants of health
S: Antimicrobial Stewardship, including quality of care
S1. Antibiotic stewardship: Program development & evaluation
S2. Antibiotic stewardship: Interventions
S3. Antibiotic stewardship: Diagnostics/diagnostic stewardship
S4. Antibiotic stewardship: Special populations
S5. Antibiotic stewardship: Non-inpatient settings
S6. Antibiotic stewardship: Trends in antimicrobial prescribing
S7. Antibiotic stewardship: Social determinants of health
T: Transplant and Immunocompromised Host Infections
T1. Studies of pre-transplant screening and evaluation
T2. Studies of empiric and pre-emptive therapy
T3. Studies of the epidemiology of infections in transplant patients and patients with impaired immunity due to underlying disease or immunosuppressive drugs
T4. Social determinants of health
V: Virology (all viruses other than HIV, HIV co-infections, and hepatitis)
V1. Studies of the epidemiology of viral infections
V2. Studies of viral pathogenesis
V3. Studies of treatment and prevention of viral infections
Y: Career and Professional Development in ID
Y1. Structual determinants and career advancement (Inclusion, Diversity, Access and Equity)
Y2. Leadership development
Y3. Policy and advocacy
Y4. Ethics, publishing, and other academic/professional affairs
Y5. Structural equity (Inclusion, Diversity, Access and Equity)
Z: COVID-2019 and co-infections
Z1. COVID: Epidemiology and screening
Z2. COVID: Infection prevention
Z3. COVID: Pathogenesis
Z4. COVID: Treatment
Z5. COVID: Complications, co-infections, and clinical outcomes
Z6. COVID: Diagnostics
Z7. COVID: Research
Z8. COVID: Global response/response in low resource settings
Z9. COVID: Special populations (e.g. pregnant women, children, immunocompromised, etc)
Z10. COVID: Impact of social distancing/mitigation measures
Z11. COVID: Vaccines
Z12. COVID: Social determinants of health
Z13. COVID: Other